| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research &Development | Director
2 companies
Malik Fady Ibraham is an EVP Research &Development at CYTOKINETICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $11.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $37.47 | $74,940.00 | -1.4% | +57.4% | - | |
| Jul 8, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $33.76 | $67,520.00 | -1.4% | +77.1% | - | |
| Jun 17, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $32.91 | $65,820.00 | -1.4% | +51.9% | - | |
| Jun 3, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $31.88 | $63,760.00 | -1.4% | +55.1% | - | |
| May 20, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $31.98 | $63,960.00 | -1.4% | +19.3% | - | |
| May 6, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $35.01 | $70,020.00 | -1.4% | +7.7% | +86.5% | |
| Apr 22, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $38.11 | $76,220.00 | -1.4% | -2.2% | - | |
| Apr 8, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $36.18 | $72,360.00 | -1.4% | -3.5% | +90.3% | |
| Mar 18, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sale+OE | 2,000 | $43.58 | $87,160.00 | -1.4% | -22.0% | +43.7% | |
| Mar 17, 2025 | CYTK Cytokinetics Inc | EVP Research &Development | Sell | 4,389 | $44.38 | $194,783.82 | -4.2% | -24.8% | +38.3% |